Publications by authors named "Michael Gejl"

Claim this Profile
R
Relation of Insulin Resistance to Brain Glucose Metabolism in Fasting and Hyperinsulinemic States: A Systematic Review and Meta-analysis.
Nicole J Jensen, Ane J Porse, Helena Z Wodschow, Helene Speyer, Jesper Krogh, Michael Gejl

J Clin Endocrinol Metab· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Alzheimer's disease, amyloid beta accumulation is a protective mechanism that ultimately fails.
Elise Brøchner Rischel, Michael Gejl, Birgitte Brock, Jørgen Rungby, Albert Gjedde

Alzheimers Dement· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.
Malin Nilsson, Nicole Jensen, Michael Gejl, Marianne L Bergmann, Heidi Storgaard

Diabetologia· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different mechanisms involved in liraglutide and glucagon-like peptide-1 vasodilatation in rat mesenteric small arteries.
Maj Bangshaab, Alejandro Gutierrez, Khiem Dinh Huynh, Jakob Schöllhammer Knudsen, Daniel Dias Rufino Arcanjo, Michael Gejl

Br J Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of incretin hormones on cerebral glucose metabolism in health and disease.
Malin Nilsson, Albert Gjedde, Birgitte Brock, Michael Gejl, Jørgen Rungby

Neuropharmacology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial.
Michael Gejl, Albert Gjedde, Birgitte Brock, Arne Møller, Eelco van Duinkerken

Diabetologia· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in humans: Reduced glucose uptake, unchanged oxygen consumption and increased blood flow by positron emission tomography. A randomized, controlled trial.
Mads Svart, Lars C Gormsen, Jakob Hansen, Dora Zeidler, Michael Gejl

PLoS One· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment.
Michael Gejl, Birgitte Brock, Lærke Egefjord, Kim Vang, Jørgen Rungby

Sci Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
Rune B Nielsen, Lærke Egefjord, Hugo Angleys, Kim Mouridsen, Michael Gejl

Alzheimers Dement· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain Trauma.
Brian DellaValle, Gitte S Brix, Birgitte Brock, Michael Gejl, Jørgen Rungby

Front Pharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats.
Brian DellaValle, Gitte S Brix, Birgitte Brock, Michael Gejl, Anne M Landau

Front Pharmacol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse Mismatch Pattern in Cardiac 18F-FDG Viability PET/CT Is Not Associated With Poor Outcome of Revascularization: A Retrospective Outcome Study of 91 Patients With Heart Failure.
Allan Kjeldsen Hansen, Michael Gejl, Kirsten Bouchelouche, Lars Poulsen Tolbod, Lars Christian Gormsen

Clin Nucl Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vagotomy and subsequent development of diabetes - A nested case-control study.
Jakob Starup-Linde, Michael Gejl, Per Borghammer, Filip K Knop, Søren Gregersen

Metabolism· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial.
Michael Gejl, Albert Gjedde, Lærke Egefjord, Arne Møller, Søren B Hansen

Front Aging Neurosci· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients.
Johan Stender, Ron Kupers, Anders Rodell, Aurore Thibaut, Camille Chatelle, Michael Gejl

J Cereb Blood Flow Metab· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of cardiovascular disease: the effects of diabetes and anti-diabetic drugs - a nested case-control study.
Michael Gejl, Jakob Starup-Linde, Jan Scheel-Thomsen, Soeren Gregersen, Peter Vestergaard

Int J Cardiol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia.
Michael Gejl, Susanne Lerche, Annette Mengel, Niels Møller, Bo Martin Bibby

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited.
Jan Hansen, Birgitte Brock, Hans Erik Bøtker, Albert Gjedde, Jørgen Rungby, Michael Gejl

Rev Endocr Metab Disord· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
At the centennial of Michaelis and Menten, competing Michaelis-Menten steps explain effect of GLP-1 on blood-brain transfer and metabolism of glucose.
Michael Gejl, Jørgen Rungby, Birgitte Brock, Albert Gjedde

Basic Clin Pharmacol Toxicol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.
Michael Gejl, Susanne Lerche, Lærke Egefjord, Birgitte Brock, Niels Møller

Front Neuroenergetics· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.
Michael Gejl, Lærke Egefjord, Susanne Lerche, Kim Vang, Bo Martin Bibby

J Cereb Blood Flow Metab· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial.
Lærke Egefjord, Michael Gejl, Arne Møller, Hans Brændgaard, Hanne Gottrup

Dan Med J· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes.
Ann Mosegaard Bak, Lærke Egefjord, Michael Gejl, Charlotte Steffensen, Chalotte Willemann Stecher

Expert Opin Ther Targets· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis